Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GNLX
#3867
Genelux Corporation - Common Stock
2.8
9
USD
-0.02%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.36%
Monthly Change
-3.67%
6 month change
+11.15%
Year Change
-6.17%
Previous Close
2.9
6
Open
2.8
9
Low
2.8
9
High
2.8
9
Volume
8
Markets
US Stock Market
Healthcare
Biotechnology
GNLX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2023
2024
2025
Total assets
27.89 M
34.72 M
19.03 M
Total liabilities
8.42 M
8.44 M
7.48 M
Total equity
19.47 M
26.27 M
11.54 M
Total liabilities & shareholders' equities
27.89 M
34.72 M
19.03 M
Total debt
900 K
—
—
Net debt
-22.29 M
—
—
News
Genelux prices public offering of 6.67 million shares at $3 each
Genelux stock falls after announcing proposed public offering
Genelux announces proposed public offering of common stock
Genelux stock maintains Buy rating at H.C. Wainwright on promising cancer trial data
Genelux appoints Jason Litten as chief medical officer
Cappello, Genelux CTO, sells $14k in GNLX stock
Genelux president sells $66k in GNLX stock
Genelux SVP, Yu Yong, sells shares worth $16k
Lake Street Capital Markets initiates Genelux stock with Buy rating
Genelux stock maintains Buy rating at H.C. Wainwright amid sector news
Lucid Capital Markets initiates Genelux stock with Buy rating, $10 target